BIOMAT Database Logo BIOMAT Database Logo

PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines. 2001

K Kondo, and M Yao, and K Kobayashi, and S Ota, and M Yoshida, and S Kaneko, and M Baba, and N Sakai, and T Kishida, and S Kawakami, and H Uemura, and Y Nagashima, and Y Nakatani, and M Hosaka
Department of Urology, Yokohama City University School of Medicine, Yokohama, Japan.

Extensive allelotyping studies have implicated several tumor-suppressor loci on chromosomes 3p, 5q, 6q, 8p, 9pq, 10q, 11q, 14q, 17p, 18q and 19p in human kidney tumorigenesis. The PTEN (also called MMAC1 and TEP1) gene, a candidate tumor suppressor located at chromosome 10q23.3, is mutated in a variety of sporadic malignancies as well as in patients with Cowden disease. To investigate the potential role of the PTEN gene in renal tumorigenesis, we searched for abnormalities of the gene in 68 primary renal-cell carcinomas (RCCs) as well as in 17 renal carcinoma-derived cell lines, using DNA-SSCP, sequencing and microsatellite analysis. Five of 68 (7.5%) primary RCCs exhibited intragenic mutations (3 missense, 1 deletion and 1 splice-site), and 1 of 17 (5.9%) cell lines had an insertion mutation. Loss of heterozygosity of the PTEN gene occurred in 25% of primary RCCs, including the 3 cases with intragenic mutation and the 1 PTEN-mutated cell line. Clinical and histopathological examinations revealed that 4 of the 5 primary tumors with PTEN mutation were high-grade, advanced clear-cell RCCs with distant metastases or renal vein tumor invasions, resulting in poor prognostic courses. The other was a low-stage papillary/chromophilic RCC. Our data suggest that PTEN mutation is observed in a subset of RCCs and that, especially in clear-cell RCCs, it occurs as a late-stage event and may contribute to the invasive and/or metastatic tumor phenotype.

UI MeSH Term Description Entries
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010744 Phosphoric Monoester Hydrolases A group of hydrolases which catalyze the hydrolysis of monophosphoric esters with the production of one mole of orthophosphate. Phosphatase,Phosphatases,Phosphohydrolase,Phosphohydrolases,Phosphomonoesterase,Phosphomonoesterases,Phosphoric Monoester Hydrolase,Hydrolase, Phosphoric Monoester,Hydrolases, Phosphoric Monoester,Monoester Hydrolase, Phosphoric
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D051059 PTEN Phosphohydrolase A lipid phosphatase that contains a C2 DOMAIN and acts on phosphatidylinositol-3,4,5-trisphosphate to regulate various SIGNAL TRANSDUCTION PATHWAYS. It modulates CELL GROWTH PROCESSES; CELL MIGRATION; and APOPTOSIS. Mutations in PTEN are associated with COWDEN DISEASE and PROTEUS SYNDROME as well as NEOPLASTIC CELL TRANSFORMATION. MMAC1 Protein,Mutated In Multiple Advanced Cancers 1 Protein,PTEN Phosphatase,PTEN Protein,PTEN Protein Phosphatase,Phosphatase and Tensin Homologue on Chromosome Ten Protein,Phosphatase, PTEN,Phosphatase, PTEN Protein,Phosphohydrolase, PTEN,Protein Phosphatase, PTEN
D019656 Loss of Heterozygosity The loss of one allele at a specific locus, caused by a deletion mutation; or loss of a chromosome from a chromosome pair, resulting in abnormal HEMIZYGOSITY. It is detected when heterozygous markers for a locus appear monomorphic because one of the ALLELES was deleted. Allelic Loss,Heterozygosity, Loss of,Allelic Losses,Heterozygosity Loss
D020133 Reverse Transcriptase Polymerase Chain Reaction A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols. Polymerase Chain Reaction, Reverse Transcriptase,Reverse Transcriptase PCR,PCR, Reverse Transcriptase,Transcriptase PCR, Reverse
D025521 Tumor Suppressor Proteins Proteins that are normally involved in holding cellular growth in check. Deficiencies or abnormalities in these proteins may lead to unregulated cell growth and tumor development. Growth Suppressor Proteins,Metastasis Suppressor Protein,Metastasis Suppressor Proteins,Tumor Suppressor Protein,Protein, Metastasis Suppressor,Protein, Tumor Suppressor,Proteins, Growth Suppressor,Proteins, Metastasis Suppressor,Proteins, Tumor Suppressor,Suppressor Protein, Metastasis,Suppressor Protein, Tumor

Related Publications

K Kondo, and M Yao, and K Kobayashi, and S Ota, and M Yoshida, and S Kaneko, and M Baba, and N Sakai, and T Kishida, and S Kawakami, and H Uemura, and Y Nagashima, and Y Nakatani, and M Hosaka
PTEN/MMAC1/TEP1 involvement in primary prostate cancers.
June 1998, Oncogene,
K Kondo, and M Yao, and K Kobayashi, and S Ota, and M Yoshida, and S Kaneko, and M Baba, and N Sakai, and T Kishida, and S Kawakami, and H Uemura, and Y Nagashima, and Y Nakatani, and M Hosaka
[Correlation between the PTEN/MMAC1/TEP1 expression and cell proliferation and apoptosis in human renal cell carcinoma (RCC)].
June 2003, Ai zheng = Aizheng = Chinese journal of cancer,
K Kondo, and M Yao, and K Kobayashi, and S Ota, and M Yoshida, and S Kaneko, and M Baba, and N Sakai, and T Kishida, and S Kawakami, and H Uemura, and Y Nagashima, and Y Nakatani, and M Hosaka
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
December 1997, Cancer research,
K Kondo, and M Yao, and K Kobayashi, and S Ota, and M Yoshida, and S Kaneko, and M Baba, and N Sakai, and T Kishida, and S Kawakami, and H Uemura, and Y Nagashima, and Y Nakatani, and M Hosaka
PTEN/MMAC1 mutations in hepatocellular carcinomas.
May 1999, Oncogene,
K Kondo, and M Yao, and K Kobayashi, and S Ota, and M Yoshida, and S Kaneko, and M Baba, and N Sakai, and T Kishida, and S Kawakami, and H Uemura, and Y Nagashima, and Y Nakatani, and M Hosaka
Alternative splicing of the human PTEN/MMAC1/TEP1 gene.
December 2000, Biochimica et biophysica acta,
K Kondo, and M Yao, and K Kobayashi, and S Ota, and M Yoshida, and S Kaneko, and M Baba, and N Sakai, and T Kishida, and S Kawakami, and H Uemura, and Y Nagashima, and Y Nakatani, and M Hosaka
Colorectal carcinomas and PTEN/MMAC1 gene mutations.
December 2001, Clinical cancer research : an official journal of the American Association for Cancer Research,
K Kondo, and M Yao, and K Kobayashi, and S Ota, and M Yoshida, and S Kaneko, and M Baba, and N Sakai, and T Kishida, and S Kawakami, and H Uemura, and Y Nagashima, and Y Nakatani, and M Hosaka
PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis.
August 1999, European journal of biochemistry,
K Kondo, and M Yao, and K Kobayashi, and S Ota, and M Yoshida, and S Kaneko, and M Baba, and N Sakai, and T Kishida, and S Kawakami, and H Uemura, and Y Nagashima, and Y Nakatani, and M Hosaka
[Mutation analysis of the tumor suppressor gene PTEN/MMAC1/TEP1 in human hepatocellular carcinoma].
September 2000, Shi yan sheng wu xue bao,
K Kondo, and M Yao, and K Kobayashi, and S Ota, and M Yoshida, and S Kaneko, and M Baba, and N Sakai, and T Kishida, and S Kawakami, and H Uemura, and Y Nagashima, and Y Nakatani, and M Hosaka
Inactivation of the PTEN/MMAC1/TEP1 gene in human lung cancers.
June 1998, Genes, chromosomes & cancer,
K Kondo, and M Yao, and K Kobayashi, and S Ota, and M Yoshida, and S Kaneko, and M Baba, and N Sakai, and T Kishida, and S Kawakami, and H Uemura, and Y Nagashima, and Y Nakatani, and M Hosaka
The genetic basis of Cowden's syndrome: three novel mutations in PTEN/MMAC1/TEP1.
April 1998, Human genetics,
Copied contents to your clipboard!